Skip to content

Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes

Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04696640
Enrollment
39
Registered
2021-01-06
Start date
2021-06-03
Completion date
2022-05-25
Last updated
2022-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Brief summary

This project explores the feasibility and utility of remote glucose monitoring for a cohort of children and adolescents with type 1 diabetes (T1D) cared for at UC Davis Health (UCDH).

Interventions

Participants' glucose data will be monitored by the study team using population analytic reports. Participants who either have excessive hypoglycemia or hyperglycemia on these reports will be contacted by a pediatric endocrinologist (the principal investigator) to discuss any necessary adjustments to their home diabetes management plans. This intervention will be in addition to their usual care (regular visits at the UC Davis Pediatric Endocrinology clinic).

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 20 Years
Healthy volunteers
No

Inclusion criteria

* Diagnoses of type 1 diabetes with a duration of greater than or equal to 12 months * Use of a continuous glucose monitor (CGM) for greater than or equal to 6 months * Intention to continue receiving care at the UC Davis Health Pediatric Diabetes clinic.

Exclusion criteria

* Patient's CGM cannot be uploaded to Glooko

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of remote glucose monitoring for pediatric T1D patients who receive care at UC Davis Health1 month baseline periodProportion of participants who have successfully established remote glucose monitoring by the end of the baseline period.
Change in hemoglobin A1c (HbA1c)Initiation = 1 month after enrollment, Study completion = 7 months after enrollmentHbA1c at study completion minus the HbA1c at initiation

Secondary

MeasureTime frameDescription
Hyperglycemic rangeMonths 1-7 after enrollmentPercentage of time spent in hyperglycemic range (generated from continuous glucose monitor)
Hypoglycemic rangeMonths 1-7 after enrollmentPercentage of time spent in hypoglycemic range (generated from continuous glucose monitor)
Data-sharing experience survey1 month after enrollmentSurvey asking about patient's experience with data-sharing
Remote patient monitoring surveyMonth 7 after enrollmentSurvey asking about patient's experience with remote patient monitoring
Overall continuous glucose monitor (CGM) wear timeMonths 1-7 after enrollmentPercentage of time spent wearing continuous glucose monitor (generated from continuous glucose monitor)
Target Glucose RangeMonths 1-7 after enrollmentPercentage of time spent in target glucose range (generated from continuous glucose monitor)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026